FDA Compliance for Drug and Medical Device Labeling and Off Label Promotion: What is Acceptable or Not Acceptable? - Webinar By GlobalCompliancePanel

14 March 2012, Wilmington, United States

Introduction

This webinar is intended to discuss the best practices for disseminating off-label information by firms for their FDA-approved or cleared products (drugs for both human and animals and medical devices for humans). This webinar will also discuss the best practices for responding to both non-public and public unsolicited requests made through emerging electronic media (e.g., social media or other public electronic media).